Automated production of oxygen-15 labeled butanol for PET measurement of regional cerebral blood flow.

Because [15O]butanol is the radiopharmaceutical of choice for PET studies of cerebral perfusion and neurological activation, we have developed a microprocessor-controlled radiosynthetic system for the preparation of this radiotracer in up to ten batches at a time. An IBM-compatible minicomputer was programmed to direct the reaction of molecular [15O]oxygen with tri-(n-butyl)borane bound to alumina, followed by purification of product [15O]butanol via solid phase extraction with C18 Sep-Paks and sterile filtration. Routine batch yields of over 150 mCi were achieved with a preparation turn-around time of 6.0 min. The final product had high radiochemical purity, low chemical impurity, and was sterile and apyrogenic. This radiopharmaceutical production system is reliable and suitable for tracer production in clinical PET imaging centers.

[1]  M. Raichle,et al.  Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  M. Welch,et al.  Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16 alpha-fluoroestradiol-17 beta. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  K. Gould,et al.  Preparation of oxygen-15 butanol for positron tomography. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  M. Berridge,et al.  A routine, automated synthesis of oxygen-15-labeled butanol for positron tomography. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  M J Welch,et al.  Automated production of several positron-emitting radiopharmaceuticals using a single laboratory robot. , 1988, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[6]  M. Raichle,et al.  Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M. Mintun,et al.  Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  M. Welch,et al.  A remote system for the routine production of oxygen‐15 radiopharmaceuticals , 1985 .

[9]  M. Welch,et al.  Elimination of contaminant Kryptofix 2.2.2 in the routine production of 2-[18F]fluoro-2-deoxy-D-glucose. , 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[10]  M J Welch,et al.  Positron Emission Tomographic Measurement of Cerebral Blood Flow and Permeability—Surface Area Product of Water Using [15O]Water and [11C]Butanol , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  M. Mintun,et al.  A Noninvasive Approach to Quantitative Functional Brain Mapping with H215O and Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  M E Raichle,et al.  Evidence of the Limitations of Water as a Freely Diffusible Tracer in Brain of the Rhesus Monkey , 1974, Circulation research.

[13]  M J Welch,et al.  Blood-brain barrier permeability of 11C-labeled alcohols and 15O-labeled water. , 1976, The American journal of physiology.

[14]  J. Fowler,et al.  Synthesis of 15O-labeled butanol via organoborane chemistry. , 1985, The International journal of applied radiation and isotopes.